Tag: ALASTIN Skincare Inc

All

New from ALASTIN Skincare: TransFORM Body Treatment with TriHex Technology

ALASTIN Skincare Inc will launch its newest product—TransFORM Body Treatment with TriHex Technology—at the American Society for Dermatologic Surgery (ASDS) Annual Meeting in Phoenix, October 11-14 in Phoenix.

ALASTIN Skincare Partners with HintMD Subscription Platform
TransFORM + Cryolipolysis Combo Effective, Study Suggests
ALASTIN Receives 4th Patent for Its TriHex Technology
Study Highlights Results of ALASTIN Skincare’s TransFORM Body Treatment with TriHex Technology
ALASTIN Skincare Announces Issuance of Fifth And Sixth US Patent Incorporating TriHex Technology
Galderma to Acquire Award-Winning ALASTIN Skincare
Galderma Successfully Completes Acquisition of ALASTIN Skincare

All

Sorry, No Posts Found

All

Galderma Launches First OBT Hyaluronic Acid Injectables in Japan

Restylane Defyne and Refyne expand the company's portfolio to four products in the Japanese market, designed for facial wrinkle correction.

How VYC-12L Performs in Treating Horizontal Neck Lines
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo
FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

Tag: ALASTIN Skincare Inc

All

New from ALASTIN Skincare: TransFORM Body Treatment with TriHex Technology

ALASTIN Skincare Partners with HintMD Subscription Platform

TransFORM + Cryolipolysis Combo Effective, Study Suggests

ALASTIN Receives 4th Patent for Its TriHex Technology

Study Highlights Results of ALASTIN Skincare’s TransFORM Body Treatment with TriHex Technology

ALASTIN Skincare Announces Issuance of Fifth And Sixth US Patent Incorporating TriHex Technology

Galderma to Acquire Award-Winning ALASTIN Skincare

Galderma Successfully Completes Acquisition of ALASTIN Skincare

All

Sorry, No Posts Found

All

Galderma Launches First OBT Hyaluronic Acid Injectables in Japan

How VYC-12L Performs in Treating Horizontal Neck Lines

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links